Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 5.880

-4.9%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (3337)	4/15/2013 8:18:18 AM
From: richardred	of 7256

Life Tech in $13.6 billion buyout by Thermo Fisher Reuters – 6 minutes ago (Reuters) - Genetic testing equipment maker Life Technologies Corp has agreed to a $13.6 billion cash buyout by Thermo Fisher Scientific Inc, in one of the year's biggest corporate takeovers. The acquisition values Life Tech at $76 per share and would catapult Thermo Fisher into the hot field of genetic sequencing where researchers, drugmakers and doctors are uncovering the genetic factors underpinning diseases to better tailor treatments to patients. The offer represents a premium of about 12 percent to Life Tech's Friday close. Life Tech shares were up 8 percent at $73.40 before the bell. They closed at $68 on Friday on the Nasdaq. Thermo Fisher shares were up 1 percent. "The acquisition of Life Technologies enhances all three elements of our growth strategy: technological innovation, a unique customer value proposition and expansion in emerging markets," Thermo Fisher CEO Marc Casper said in a statement. Thermo Fisher expects the deal to close early in 2014 and immediately add to its adjusted earnings. It will also assume Life Tech's net debt of about $2.2 billion as at end 2012. The scientific and laboratory instruments maker has obtained committed bridge financing from J.P. Morgan and Barclays. Life Tech' board met on Saturday to review three takeover offers. Sources familiar with the matter told Reuters on Sunday the company chose Thermo Fisher over Sigma-Aldrich Corp, a maker of chemicals for research laboratories, and a private equity consortium consisting of Blackstone Group, Carlyle Group, KKR & Co and Temasek Holdings. J.P. Morgan and Barclays acted as financial advisors to Thermo Fisher, while Deutsche Bank Securities and Moelis & Co advised Life Tech. finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next